The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction.

  • 3 June 1988
    • journal article
    • Vol. 259  (21) , 3158-60
Abstract
No abstract available

This publication has 0 references indexed in Scilit: